Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

M. J. Maurer, T. M. Habermann

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al'. Together they form a unique fingerprint.